Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Orascom Development - Sponsored Research (ODHN.S)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (CHF)	Price Target (CHF)	Rating
2021-08-20	11.30	-	No Rating
2021-08-30	11.44	12.10	Neutral
2021-12-10	11.00	12.05	Neutral
2022-05-09	8.54	9.45	Neutral
2022-10-24	6.80	7.20	Neutral
2023-02-16	7.60	7.65	Neutral
2024-01-23	4.53	5.10	Neutral
2024-03-06	4.33	4.60	Neutral
2024-07-03	4.28	4.20	Neutral

Disclosures

UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
UBS has entered into a contract with SIX whereby UBS may (at its discretion) provide research coverage about issuers nominated by SIX. Under the terms of that contract UBS will receive a flat fee of CHF 30,000 per annum from SIX for a period of two years from the time of initiation for the creation and dissemination of research about the relevant issuer. This issuer is covered by UBS pursuant to that contract.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.